|
And If You Stay in the Snowy North
Seniors who skip the trek to Florida, Arizona or other snowbird destinations, deciding to tough it out in cold climates, can keep themselves safe and comfortable by following a few simple steps, said Dr. Sharon Brangman, a member of the American Geriatrics Society and professor of medicine at SUNY Upstate Medical University, Syracuse, N.Y.
- Stay indoors if it's brutally cold. That's especially good advice if it's windy and cold, which can make you feel colder.
- Assemble a winter wardrobe. That includes clothes you can layer, such as a sweater that goes over a long-sleeved T-shirt, a hat, gloves or mittens, boots that are flat with nonskid soles, a warm coa
'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved | |
Page: 1 2 3
Related medicine news :
1. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
2. Warning - Beware of Counterfeit Coda(R) Products
3. Beware Holiday Toys That Can Injure Young Eyes
4. Bacteria beware: MIT student invents knock-out punch for antibiotic resistance
5. Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper
6. Going barefoot? Beware!
7. Beware the Blackberry Thumb
8. Beware of Ten Mistakes after Social Security Denies Disability Benefits
9. Beware Botox Bargains in Tough Economic Times
10. Beware of Toxic Toys This Holiday Season
11. Kaiser Permanente Achieves Climate Action Leader Status
Related Image: 'Snowbirds' Beware the Climate Changes |
(Date:12/1/2009)..., , RED BANK, N.J., Dec. 1 /PRNewswire/ ...rs know breastfeeding is ideal for their babies an...o decide what works best for them and their famili...inr.mediaseed.tv/IFC_37156/ ,, The survey of m...d that most mothers (83%) made their infant feedin... (Date:12/1/2009)...iscovery could aid in development of simple screen...1 (HealthDay News) -- In a finding that could lead... U.S. researchers have identified immune system ma...ple at high risk for lung cancer. , The researc...mples from 137 people with non-small cell lung ca... (Date:12/1/2009)...DC urges H1N1 vaccination because pandemic,s cours.... 1 (HealthDay News) -- A U.S. health official sai... be on the wane nationally, but many experts agree...r. , The flu is now widespread in 32 states -- ... Frieden, director of the U.S. Centers for Disease... (Date:12/1/2009)... Ever thought you could qu...! Kevin Arthur Smith,s groundbreaking new system f...y, permanent. In just twenty eight days your cravi... , (PRWEB) December 1, 20...uring her eight-year addiction to nicotine, smokin... (Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog... Breaking Medicine News(10 mins):Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3...ill, arsenic also can prolong the lives of patient...aturday found.
"This study shows that even...arlier in the course of treatment," said Dr. Bayar...erican Society of Oncology (ASCO) which brought to... ...JAMA, has identified novel genetic mutations linke... that these mutations are due to both independent ...as been released early to coincide with its presen...is the second most common cause of cancer death wo... ...sburgh Medical Center (UPMC) study presented at th...al Oncology (ASCO) in Chicago and published as Abs...ted for follicular lymphoma, a slow-growing type o...to the treatment and since only a short-course of ... ...nounced follow-up data from a Phase 2 clinical tri...ch was conducted by the Johns Hopkins Sidney Kimme...ith operable pancreatic cancer who received GVAX a... to be 26.8 months, a result which compares favora... ...end, even if it is all subtle, as in Canada appare...e hard to pin down is more dangerous to mental hea...dy of 180 Korean immigrants living in Canada.
...lead author Samuel Noh, professor of psychiatry at... ...g of SNM, the world's largest society for molecula...man researchers stated that early metabolic imagin...ely identifies patients responding to chemotherapy...the treatment of common solid tumors," said Ken He... Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2(Date:12/1/2009)...TER, N.J., Dec. 1 Tibotec Therapeu...s, L.P., announced today that it is launching a ne...g women and people of color living with HIV/AIDS. ...ducational events, media outreach and a new Web si...g learnings from the GRACE study, the largest clin... (Date:12/1/2009)...D CITY, Calif., Dec. 1 Codexis, In...p and the signing of its second agreement this yea...rld,s largest generic drug manufacturer. The new ...products. Codexis announced an earlier agreement ...ent, Teva will use Codexis biocatalysis technology... (Date:12/1/2009)...STON, Dec. 1 An expert f...XL ), a leading global biopharmaceutical services ...ve approaches to drug development in Asia at the P...ence, being held December 1-3, 2009 at the Interco... of the conference, which is focused on maximizing... Breaking Medicine Technology:Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Codexis Expands Collaboration with Teva 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4What scientists know about jewel beetle shimmer 9338 1What scientists know about jewel beetle shimmer 9338 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 1R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 3R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 4R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 5R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 6R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 7R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 8Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals... ...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals... ...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals... ...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals... Medicine Products:
|
